| Systemic therapy for advanced hepatocellular carcinoma: ASCO guideline JD Gordan, EB Kennedy, GK Abou-Alfa, MS Beg, ST Brower, TP Gade, ... Journal of Clinical Oncology 38 (36), 4317-4345, 2020 | 419 | 2020 |
| Increased risk for hepatocellular carcinoma persists up to 10 years after HCV eradication in patients with baseline cirrhosis or high FIB-4 scores GN Ioannou, LA Beste, PK Green, AG Singal, EB Tapper, AK Waljee, ... Gastroenterology 157 (5), 1264-1278. e4, 2019 | 324 | 2019 |
| Patterns of COVID-19 testing and mortality by race and ethnicity among United States veterans: A nationwide cohort study CT Rentsch, F Kidwai-Khan, JP Tate, LS Park, JT King Jr, M Skanderson, ... PLoS medicine 17 (9), e1003379, 2020 | 292 | 2020 |
| AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma AG Singal, JM Llovet, M Yarchoan, N Mehta, JK Heimbach, LA Dawson, ... Hepatology 78 (6), 1922-1965, 2023 | 223 | 2023 |
| Association of provider specialty and multidisciplinary care with hepatocellular carcinoma treatment and mortality M Serper, TH Taddei, R Mehta, K D’Addeo, F Dai, A Aytaman, ... Gastroenterology 152 (8), 1954-1964, 2017 | 217 | 2017 |
| The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients TH Taddei, KA Kacena, M Yang, R Yang, A Malhotra, M Boxer, KA Aleck, ... American journal of hematology 84 (4), 208-214, 2009 | 187 | 2009 |
| Incidence and mortality of acute‐on‐chronic liver failure using two definitions in patients with compensated cirrhosis N Mahmud, DE Kaplan, TH Taddei, DS Goldberg Hepatology 69 (5), 2150-2163, 2019 | 173 | 2019 |
| Covid-19 testing, hospital admission, and intensive care among 2,026,227 United States veterans aged 54–75 years CT Rentsch, F Kidwai-Khan, JP Tate, LS Park, JT King Jr, M Skanderson, ... MedRxiv, 2020 | 166 | 2020 |
| Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis DS Goldberg, TH Taddei, M Serper, R Mehta, E Dieperink, A Aytaman, ... Hepatology 65 (3), 864-874, 2017 | 132 | 2017 |
| Development and performance of an algorithm to estimate the Child-Turcotte-Pugh score from a national electronic healthcare database DE Kaplan, F Dai, A Aytaman, M Baytarian, R Fox, K Hunt, A Knott, ... Clinical Gastroenterology and Hepatology 13 (13), 2333-2341. e6, 2015 | 124 | 2015 |
| Gaucher disease and malignancy: a model for cancer pathogenesis in an inborn error of metabolism PK Mistry, T Taddei, S vom Dahl, BE Rosenbloom Critical Reviews™ in Oncogenesis 18 (3), 2013 | 121 | 2013 |
| Covid-19 by race and ethnicity: a national cohort study of 6 million United States veterans CT Rentsch, F Kidwai-Khan, JP Tate, LS Park, JT King Jr, M Skanderson, ... MedRxiv, 2020 | 117 | 2020 |
| Effects of hypercholesterolemia and statin exposure on survival in a large national cohort of patients with cirrhosis DE Kaplan, MA Serper, R Mehta, R Fox, B John, A Aytaman, M Baytarian, ... Gastroenterology 156 (6), 1693-1706. e12, 2019 | 111 | 2019 |
| Risk prediction models for post‐operative mortality in patients with cirrhosis N Mahmud, Z Fricker, RA Hubbard, GN Ioannou, JD Lewis, TH Taddei, ... Hepatology 73 (1), 204-218, 2021 | 104 | 2021 |
| Starting dose of sorafenib for the treatment of hepatocellular carcinoma: a retrospective, multi-institutional study KA Reiss, S Yu, R Mamtani, R Mehta, K D’Addeo, EP Wileyto, TH Taddei, ... Journal of Clinical Oncology 35 (31), 3575, 2017 | 91 | 2017 |
| High incidence of cholesterol gallstone disease in type 1 Gaucher disease: characterizing the biliary phenotype of type 1 Gaucher disease TH Taddei, J Dziura, S Chen, R Yang, H Hyogo, C Sullards, DE Cohen, ... Journal of inherited metabolic disease 33, 291-300, 2010 | 73 | 2010 |
| Mortality and hepatic decompensation in patients with cirrhosis and atrial fibrillation treated with anticoagulation M Serper, EM Weinberg, JB Cohen, PP Reese, TH Taddei, DE Kaplan Hepatology 73 (1), 219-232, 2021 | 72 | 2021 |
| Association of BNT162b2 mRNA and mRNA-1273 vaccines with COVID-19 infection and hospitalization among patients with cirrhosis BV John, Y Deng, A Scheinberg, N Mahmud, TH Taddei, D Kaplan, ... JAMA internal medicine 181 (10), 1306-1314, 2021 | 70 | 2021 |
| Cholesterol and nonalcoholic fatty liver disease: renewed focus on an old villain TA Kerr, NO Davidson Hepatology 56 (5), 1995-1998, 2012 | 67 | 2012 |
| Postvaccination COVID‐19 infection is associated with reduced mortality in patients with cirrhosis BV John, Y Deng, KB Schwartz, TH Taddei, DE Kaplan, P Martin, ... Hepatology 76 (1), 126-138, 2022 | 52 | 2022 |
